PReMA Highlights Economic Burden of NCDs in Thailand
The Pharmaceutical Research and Manufacturers Association (PReMA) reports that non-communicable diseases (NCDs) cost the Thai economy 1.6 trillion baht annually.
According to a report from the Pharmaceutical Research and Manufacturers Association (PReMA), non-communicable diseases (NCDs) represent a significant health and economic challenge for Thailand. The association highlights that conditions such as diabetes and hypertension are major contributors to the increased risk of heart and kidney diseases among the population. PReMA estimates that the cumulative economic burden caused by these health issues reaches approximately 1.6 trillion baht per year.
For residents and long-term visitors, this data underscores the importance of proactive health management and awareness regarding lifestyle-related illnesses. While the report focuses on the macroeconomic impact, it serves as a reminder of the prevalence of these conditions within the local healthcare landscape. Travelers are encouraged to ensure they have adequate health insurance coverage and to be aware of local medical facilities capable of managing chronic conditions. As this information is based on an industry assessment, further official government data regarding specific public health policy responses or changes to healthcare accessibility remains to be confirmed. The report emphasizes the necessity of addressing these health risks to mitigate both individual suffering and the broader financial strain on the nation's resources.